RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of MYGN
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Thursday for Myriad Genetics
(Updated on Mar 28, 2024)

Sell candidate since Mar 22, 2024 Loss -4.14% PDF

The Myriad Genetics stock price fell by -0.374% on the last day (Thursday, 28th Mar 2024) from $21.40 to $21.32. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 2.36% from a day low at $21.17 to a day high of $21.67. The price has fallen in 7 of the last 10 days. Volume has increased on the last day by 93 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 560 thousand shares were bought and sold for approximately $11.95 million.

The stock lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $20.54 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 14.37% during the next 3 months and, with a 90% probability hold a price between $23.49 and $28.69 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

MYGN Signals & Forecast

There are few to no technical positive signals at the moment. The Myriad Genetics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $21.85 and $22.26. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, February 15, 2024, and so far it has fallen -9.62%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Myriad Genetics stock

Myriad Genetics finds support from accumulated volume at $21.16 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.500 between high and low, or 2.36%. For the last week, the stock has had daily average volatility of 2.77%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (MYGN) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Myriad Genetics to open at $21.39, and during the day (based on 14 day Average True Range), to move between $20.44 and $22.20, which gives a possible trading interval of +/-$0.88 (+/-4.12%) up or down from last closing price. If Myriad Genetics takes out the full calculated possible swing range there will be an estimated 8.24% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $21.16 (0.75%) than the resistance at $21.61 (1.36%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Myriad Genetics stock A Buy?

The Myriad Genetics stock holds several negative signals and despite the positive trend, we believe Myriad Genetics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -1.589 Sell Candidate Unchanged

Predicted Opening Price for Myriad Genetics of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$21.39 ( 0.312%) $21.32

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for MYGN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 21.89 2.66 %
R2 21.70 1.76 %
R1 21.58 1.21 %
Current price: 21.32
Support S1 21.20 -0.584 %
S2 21.08 -1.14 %
S3 20.89 -2.03 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 23.50 10.23 %
R2 22.24 4.32 %
R1 21.61 1.36 %
Current price 21.32
Support S1 21.16 -0.750%
S2 20.93 -1.83%
S3 19.75 -7.36%

MYGN Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jul 01, 2009 Jul 01, 2009 Jul 01, 2009 $1.75 6.73%
2 Jun 15, 2009 Jun 15, 2009 Jun 15, 2009 $1.75 4.93%

FAQ

What is the symbol for Myriad Genetics Stock and on which exchange is it traded?
The symbol for Myriad Genetics is MYGN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Myriad Genetics Stock?
The Myriad Genetics stock holds several negative signals and despite the positive trend, we believe Myriad Genetics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Myriad Genetics Stock?
Myriad Genetics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Myriad Genetics Stock.

What's the current price of Myriad Genetics Stock?
As of the end of day on the 2024-03-28, the price of an Myriad Genetics (MYGN) share was $21.32.

What is the 52-week high and low for Myriad Genetics Stock?
The 52-week high for Myriad Genetics Stock is $24.21 and the 52-week low is $13.82.

What is the market capitalization of Myriad Genetics Stock?
As of the 2024-03-28, the market capitalization of Myriad Genetics is 1.916B.

When is the next earnings date for Myriad Genetics?
The upcoming earnings date for Myriad Genetics is May 01, 2024.
Click to get the best stock tips daily for free!

About Myriad Genetics

Myriad Genetics Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing the risks for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic Test, a DNA sequencing... MYGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT